Eloxx Pharmaceuticals Inc (ELOX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2011 | 12-2010 | 06-2010 | 12-2009 | 06-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | -3,150 | N/A | -1,890 | N/A |
| Depreciation Amortization | N/A | 60 | N/A | 1,820 | N/A |
| Other Working Capital | N/A | -40 | N/A | 170 | N/A |
| Other Operating Activity | 0 | 60 | 0 | -1,670 | 0 |
| Operating Cash Flow | $N/A | $-3,070 | $N/A | $-1,570 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -2 | N/A | -1 | N/A |
| Other Investing Activity | 0 | -258 | 0 | 581 | 0 |
| Investing Cash Flow | $N/A | $-260 | $N/A | $580 | $N/A |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 0 | 140 | 0 | 1,360 | 0 |
| Financing Cash Flow | $N/A | $140 | $N/A | $1,360 | $N/A |
| Beginning Cash Position | N/A | 8,020 | N/A | 380 | N/A |
| End Cash Position | N/A | 4,830 | N/A | 750 | N/A |
| Net Cash Flow | $N/A | $-3,180 | $N/A | $370 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | -3,070 | N/A | -1,570 | N/A |
| Free Cash Flow | 0 | -3,070 | 0 | -1,570 | 0 |